Journal
BLOOD
Volume 118, Issue 13, Pages 3680-3683Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-03-344408
Keywords
-
Categories
Funding
- Lion's Cancer Research Foundation
- Umea University (Sweden)
- Stichting Translational Research CCA/VU University Medical Center
- Swedish Research Council
- NWO-VIDI
Ask authors/readers for more resources
Diagnostic platforms providing biomarkers that are highly predictive for diagnosing, monitoring, and stratifying cancer patients are key instruments in the development of personalized medicine. We demonstrate that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and show that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively. In addition, gene-expression profiling revealed a distinct RNA signature in platelets from glioma patients compared with normal control subjects. Because platelets are easily accessible and isolated, they may form an attractive platform for the companion diagnostics of cancer. (Blood. 2011; 118(13):3680-3683)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available